Penciclovir

喷昔洛韦

Report date: 2023/03/03 09:37:31
NME

Base Information

Drug NamePenciclovir
Drug Alias Namepenciclovirum潘昔洛韦喷西洛韦喷西洛维Vectavir +[11] 
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionHuman herpesvirus 1 DNA polymerase inhibitorsHuman herpesvirus 5 DNA polymerase inhibitors
TargetsHuman herpesvirus 1 DNA polymeraseHuman herpesvirus 5 DNA polymerase
Therapy Area/IndicationsHerpes ZosterHerpes LabialisHerpes Simplex +[4] 
Global Approved IndicationsHerpes LabialisHerpes SimplexHerpes Genitalis
Approved Indications in ChinaHerpes SimplexHerpes Genitalis
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1996/06/01
Country/TerritoryCanadaUnited StatesUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Pharmaceutical Group IncMylan NvLivzon Pharmaceutical Grouping Limin Pharmaceutical Factory +[4] 
Inactive CompaniesNovartis Consumer Healthcare Ltd
Active IndicationsHerpes ZosterHerpes LabialisHerpes Simplex +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeD06BB06J05AB13
Related LinksWikipediaDrugBankKEGG